Valuation: Renalytix Plc

Market Cap 13.34M 11.59M 10.82M 9.93M 18.73M 1.27B 19.06M 128M 49.97M 634M 50.09M 48.98M 2.09B P/E 2024
-0.45x
P/E 2025 -1.34x
Enterprise Value 17.94M 15.59M 14.55M 13.36M 25.19M 1.71B 25.63M 172M 67.21M 853M 67.37M 65.88M 2.81B EV / Sales 2024
11,059,330x
EV / Sales 2025 12,499,418x
Free-Float
73.31%
Yield 2024 *
-
Yield 2025 -
1 day+5.66%
1 week+5.66%
Current month+5.66%
1 month+21.74%
3 months+55.56%
6 months-51.30%
Current year-52.54%
1 week 2.5
Extreme 2.5
3
1 month 2.1
Extreme 2.1
3
Current year 1.6
Extreme 1.6
6.5
1 year 1.6
Extreme 1.6
15.5
3 years 1.6
Extreme 1.6
125
5 years 1.6
Extreme 1.6
1,080
10 years 1.6
Extreme 1.6
1,220
Manager TitleAgeSince
Chief Executive Officer 58 15/03/2018
Director of Finance/CFO 68 28/05/2024
President 65 30/04/2024
Director TitleAgeSince
Chairman 62 05/11/2024
Director/Board Member 58 15/03/2018
Chairman 74 -
Date Insider Type Main position Quantity % Market Cap.
2/13/26 A Buy

Chief Financial Officer

500 0.0001%
2/13/26 A Buy

Founder

500 0.0001%
2/13/26 A Buy

Founder

250 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+5.66%+5.66%-62.67%-97.40% 15.59M
+3.30%+1.90%+23.74%-37.74% 15.7B
+4.12%+11.89%+8.10%+120.49% 1.77B
+5.61%+5.23%-26.55%-78.66% 1.14B
-0.81%+1.50%-34.47%+21.77% 980M
+1.73%+9.16%-43.43%-50.98% 655M
-0.55%+6.82%-45.94%-52.07% 543M
+6.52%+8.56%+67.65%-47.37% 472M
+4.26%+5.64%-50.62%-47.09% 374M
+0.54%+5.71%-13.25%-32.11% 368M
Average +3.28%+2.92%-17.74%-30.12% 2.2B
Weighted average by Cap. +3.28%+0.23%+12.56%-25.54%

Financials

2024 2025
Net sales 2.29 1.99 1.86 1.71 3.21 218.18 3.27 21.9 8.58 108.8 8.6 8.41 358.87 3 2.61 2.43 2.23 4.21 285.95 4.29 28.7 11.24 142.6 11.27 11.02 470.34
Net income -33.46M -29.08M -27.15M -24.92M -46.99M -3.19B -47.81M -320M -125M -1.59B -126M -123M -5.25B -20.4M -17.73M -16.55M -15.2M -28.65M -1.94B -29.15M -195M -76.44M -970M -76.63M -74.93M -3.2B
Net Debt 3.86M 3.35M 3.13M 2.87M 5.41M 367M 5.51M 36.88M 14.45M 183M 14.48M 14.16M 604M 4.6M 4M 3.73M 3.43M 6.46M 438M 6.57M 44.01M 17.24M 219M 17.28M 16.9M 721M
Logo Renalytix Plc
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Employees
46
Date Price Change Volume
03/08/26 GBX 2.800 +5.66% 588,748
31/07/26 GBX 2.650 0.00% 102,383
30/07/26 GBX 2.650 0.00% 496,192
29/07/26 GBX 2.650 0.00% 92,762
28/07/26 GBX 2.650 0.00% 43,274

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENX Stock